The 22q11.2 deletion syndrome (22q11.2DS) is a congenital malformation
and neuropsychiatric disorder caused by meiotic chromosome rearrangements. One
of the goals of this review is to summarize the current state of basic research
studies of 22q11.2DS. It highlights efforts to understand the mechanisms
responsible for the 22q11.2 deletion that occurs in meiosis. This mechanism
involves the four sets of low copy repeats (LCR22) that are dispersed in the
22q11.2 region and the deletion is mediated by non-allelic homologous
recombination events. This review also highlights selected genes mapping to the
22q11.2 region that may contribute to the typical clinical findings associated
with the disorder and explain that mutations in genes on the remaining allele
can uncover rare recessive conditions. Another important aspect of 22q11.2DS is
the existence of phenotypic heterogeneity. While some patients are mildly
affected, others have severe medical, cognitive and/or psychiatric challenges.
Variability may be due in part to the presence of genetic modifiers. This review
discusses current genome-wide efforts to identify such modifiers that could shed
light on molecular pathways required for normal human development, cognition or
behavior.
A wide spectrum of birth defects are caused by deletions of the DiGeorge syndrome critical region (DGCR) at human chromosome 22q11. Over one hundred such deletions have now been examined and a minimally deleted region of 300kb defined. Within these sequences we have identified a gene expressed during human and murine embryogenesis. The gene, named TUPLE1, and its murine homologue, encodes a protein containing repeated motifs similar to the WD40 domains found in the beta-transducin/enhancer of split (TLE) family. The TUPLE1 product has several features typical of transcriptional control proteins and in particular has homology with the yeast Tup1 transcriptional regulator. We propose that haploinsufficiency for TUPLE1 is at least partly responsible for DiGeorge syndrome and related abnormalities.
Heterogeneity of lymphatic vessels during embryogenesis is critical for organ-specific lymphatic function. Little is known about lymphatics in the developing kidney, despite their established roles in pathology of the mature organ. We performed three-dimensional imaging to characterize lymphatic vessel formation in the mammalian embryonic kidney at single-cell resolution. In mouse, we visually and quantitatively assessed the development of kidney lymphatic vessels, remodeling from a ring-like anastomosis under the nascent renal pelvis; a site of VEGF-C expression, to form a patent vascular plexus. We identified a heterogenous population of lymphatic endothelial cell clusters in mouse and human embryonic kidneys. Exogenous VEGF-C expanded the lymphatic population in explanted mouse embryonic kidneys. Finally, we characterized complex kidney lymphatic abnormalities in a genetic mouse model of polycystic kidney disease. Our study provides novel insights into the development of kidney lymphatic vasculature; a system which likely has fundamental roles in renal development, physiology and disease.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.